Differential Diagnosis

Splenomegaly with platelet sequestration

Increased platelet destruction by an immune mechanism; can occur as a result of:

  • Heparin-induced thrombocytopenia (HIT)

  • Idiopathic or immune thrombocytopenic purpura (ITP)

  • Drug (other than heparin)-induced thrombocytopenia

  • Post-transfusion purpura (PTP)

Increased platelet destruction by non-immune mechanisms, as caused by:

  • DIC

  • Hemolytic uremic syndrome (HUS)

  • Thrombotic thrombocytopenic purpura (TTP)

Decreased platelet production most often occurs after exposure to drugs (e.g., chemotherapeutic agents) that suppress synthesis of new platelets or by infiltration of the marrow by tumor or other structures.

Suggested Additional Lab Testing

Platelet count establishes presence or absence of thrombocytopenia; 100,000 functional platelets/µL is usually considered adequate for any challenge to hemostasis.

Workup for DIC:

  • PT

  • D-dimer or FDP

  • Fibrinogen

  • Peripheral blood smear to check for schistocytes

Test for HIT:

  • Most often available is ELISA for antibody to platelet factor 4/heparin complex

  • ITP is a diagnosis of exclusion.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs